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Abstract
Background: sAPPa released after a secretase cleavage of Amyloid Precursor Protein (APP) has several functions including
the stimulation of neurite outgrowth although detailed morphometric analysis has not been done. Two domains involved in
this function have been described and are present in sAPPb released at the first step of amyloid peptide cleavage, raising
the possibility that sAPPb could also stimulate neurite outgrowth. We investigated the morphological effects of sAPPa and
sAPPb on primary neurons and identified a key signaling event required for the changes observed.
Methodology/Principal Findings: Final concentrations of 50 to 150 nM bacterial recombinant sAPPa or sAPPb added to
primary neuronal cultures after 1 day in vitro decreased cell adhesion 24 hours later and primary dendrite length 96 hours
later. 150 nM sAPPa and sAPPb induced a similar increase of axon outgrowth, although this increase was already significant
at 100 nM sAPPa. These morphological changes induced by sAPPs were also observed when added to differentiated
neurons at 5 days in vitro. Real time PCR and immunocytochemistry showed that sAPPa and sAPPb stimulated Egr1
expression downstream of MAPK/ERK activation. Furthermore, in primary neurons from Egr1 2/2 mice, sAPPs affected
dendritic length but did not induce any increase of axon length.
Conclusion/Significance: sAPPa and sAPPb decrease cell adhesion and increase axon elongation. These morphological
changes are similar to what has been observed in response to heparan sulfate. The sAPPa/sAPPb stimulated increase in
axon growth requires Egr1 signaling. These data suggest that sAPPb is not deleterious per se. Since sAPPb and sAPPa are
present in the embryonic brain, these two APP metabolites might play a role in axon outgrowth during development and in
response to brain damage.
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Introduction
In addition to being a key molecule in Alzheimer’s disease,
Amyloid Precursor Protein (APP) and its metabolites play important
roles during brain development [1]. APP appears at embryonic (E)
day 9.5 in mouse when the first neurons have started to differentiate
[2]. APP cleavage by alpha secretase generates secreted APP
(sAPPa), which is present during brain development [3]. sAPPa
stimulates the proliferation of neural stem cells from embryonic rat
neocortex and from adult mouse brain [4,5]. sAPPa has
neurotrophic and neuroprotective properties, and recently, it was
shown to increase LTP and spatial memory [1,6,7].
Specificdomains ofsAPPa havebeen identified that contribute to
neuroprotection and others to the stimulation of neurite outgrowth
in vitro [6]. However, little is known about the effects of sAPPb,
generated by beta secretase cleavage, and which shares the same
sequence as the sAPPa except for the last 16 C-terminal amino
acids. Cleavage by b secretase occurs upstream to c secretase
cleavage and generates the amyloid peptide, which can form soluble
neurotoxic oligomers and is the main component of extracellular
amyloid deposits in Alzheimer pathology. After cleavage of the
amyloid peptide the APP C-terminal domain is released and enters
the nucleus where it can affect gene expression [8]. APP cleavage
and signalingalsooccur during brainembryogenesis and seem to be
necessary for normal brain development [9–11]. A recent report
showed that in peripheral neurons deprived growth factor and that
undergo apoptosis, b cleavage releases sAPPb, which binds to DR6
inducing neurodegeneration [12]. Compared to sAPPa, sAPPb is
100-fold less potent in protecting hippocampal neurons against
excitotoxicity, amyloid toxicity and glucose deprivation [13].
Although sAPPa stimulates neurite outgrowth, a detailed morpho-
metric analysis has never been done. Two domains located between
residues96–110 and 319–335insAPPaarereportedthat contribute
to neurite outgrowth. The former region is also a binding site for
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16301heparan sulfate proteoglycans (HSPG) [14,15]. Both of these
domains are present in the sAPPb, suggesting that sAPPb could also
stimulate neurite outgrowth.
The signaling pathways involved in sAPPa neuroprotection
have been characterized. Less well known are the signaling
pathways involved in sAPPa neurotrophic properties. Recently,
we and others have shown that mitogen activated protein kinase
(MAPK)/extracellular signal-regulated (ERK) pathway is activat-
ed during neurite outgrowth of neural stem cell derived neurons or
primary neurons in response to sAPPa [16–18].
Here, we examined whether sAPPb also stimulated neurite
outgrowth and compared this with sAPPa. We observed that both
induce similar and specific effects on axon outgrowth and that
their effects require Egr1 signaling.
Methods
sAPP-Fc production
A plasmid encoding human sAPPa (695 amino acid form) fused
to the Fc fragment of human IgG was transfected into Cos-7 cells
and sAPP-Fc purified from the conditioned medium on a protein
A-sepharose column using standard procedures [5].
Cloning, expression and purification of recombinant
sAPPa and sAPPb
We first generated a DNA fragment harbouring the coding
sequence for sAPPa and sAPPb by PCR amplification of a plasmid
encoding for human APP695. For both proteins the forward
primer (Eurofins MWG Operon) was 59-ACTGTCGACTA-
TGCTGCCCGGTTTGGCA-39 containing Sal1 restriction site.
The reverse primers were 59-CAGCGGCCGCTTTTTGAT-
GATGAACTTC-39 for sAPPa and 59-CAGCGGCCGCCA-
TCTTCACTTCAGAGA-39 for sAPPb, both primers containing
Not1 restriction site. The amplified DNA were cloned into pGEX-
6P-2 (GE Healthcare), containing a PreScission Protease sequence
upstream to the Sal1 restriction site for cleaving the GST tag from
the fused protein. The generated plasmids were sequenced.
The plasmids were transformed into E.coli strain BL21pLysS
(Invitrogen). The transformed cells were grown in 25 ml of YT
broth medium containing 100 mg/ml ampicilline at 37uCf o r
16 h then diluted 1/10 in the same medium and grown to an
absorbance of 0.3 at 600 nm. Proteins encoded by the plasmids
were induced by addition of isopropyl-b-D-thiogalactopyrano-
side (IPTG) to a final concentration of 0.1 mM and incubated for
an additional 3 h at 20uC. The bacteria were then collected by
centrifugation, resuspended in 5 ml of phosphate buffer saline
(PBS) containing 0.2 mg/ml lysozyme and 5 mM dithiothreitol,
and lysed with a sonicator 1 min at 4uC. Triton X100 1% was
added and the mixture was stirred gently for 2 h at 4uCa n dt h e n
centrifuged 15 min at 14,000 g at 4uC. The supernatants were
added to a glutathione-sepharose column equilibrated with
binding buffer. After washings, proteins were eluted from
glutathione-sepharose beads with PreScission Protease (GE
Healthcare) at 4uC during 24 h, according to the manufacturer’s
instructions. Recombinant proteins were analyzed by SDS-
PAGE for their respective MW and checked by immunoblot
using the N-terminal APP antibody (MAB 348, Chemicon
International) recognizing both proteins, while the C-terminal
specific sAPPa antibody (6E10, Signet) did not recognize the
sAPPb.
Ethics statement
All animal procedures followed the French and European
Union regulations. The protocol of animal euthanasia was
performed according to French government ethical laws decree
86/609 and approved by the local Ethics Committee (Direction
de ´partementale des services ve ´te ´rinaires de Paris, service de la
protection et sante ´ animales et de la protection de l’environne-
ment) permit number: 75–1003.
Primary cortical neurons
Primary neuronal cultures from cortex were performed from
E16 mouse embryos from Swiss strain mice. Briefly, dissociated
cells were plated (15610
3 neurons/well for morphometric analysis,
and 40610
3 neurons/well for adhesion assays) in 16.2 mm
diameter plastic wells coated with 1.5 mg/ml polyornithin. For
immunocytochemical studies neurons were plated on glass
coverslips coated with 15 mg/ml polyornithine at a density of
10
5 neurons/well. Neurons were grown in a define medium free of
serum and supplemented with hormones, proteins, and salts as
previously described [19]. Final concentrations of 50 to 150 nM
sAPP-Fc, sAPPa or sAPPb were added to neurons after 1 day in
vitro (DIV) for the different tests. In some experiments final
concentration of 150 nM sAPPs was added to the neurons after
5DIV.
Morphometric analysis
After addition of sAPPs on 1DIV neurons, cells were fixed 4
days later with 4% paraformaldehyde for 40 min at room
temperature. In experiments where neurons were treated for 1 h
with 5 mM of ERK1,2 inhibitor (UO126, Sigma), the cells were
fixed 2 days later as above. Then neurons were washed twice in
PBS and incubated with anti-b tubulin (1/5000, Sigma) overnight
at 4uC. After two washes in PBS, neurons were incubated with a
biotinylated anti-mouse antibody, and immunoreactivity was
visualized using an Elite ABC kit (Vector Laboratories) and 3,39-
diaminobenzidin as the chromogen. For each condition of each
experiment, about 60 neurons were digitally acquired and
morphologically analyzed with NeuronJ software. The length of
the longest neurite, the length of all primary dendrites and the
number of primary dendrites for each neuron were evaluated
independently by two different experimenters (SC and LD).
Statistical analysis was performed using ANOVA and post-hoc
Scheffe’s test (StatView). The data (Mean 6 S.E.M.) are presented
in supplemental tables and the corresponding graphs are presented
in figures. Significance is shown in the figure legends.
Adhesion assays
For adhesion assays, neurons grown in presence of sAPPs for
24 h were agitated for 10 min at 250 revolutions/min at room
temperature, the medium containing detached cells was removed
and the remaining neurons adhering to the bottom of the well
were fixed with 2.5% glutaraldehyde in PBS for 30 min, rinsed in
PBS and stained with Toluidine blue [20]. For each condition of
each experiment, neurons on a diameter of 3 wells were counted
independently by two different experimenters (SC and LD).
Immunocytochemistry
For Egr1 immunostaining, neurons after 1DIV were incubated
or not for 1 h with 5 mM of ERK1,2 inhibitor (UO126, Sigma),
and treated 2 h with sAPPs. Neurons were then fixed as above,
rinsed in PBS, and non-specific binding sites saturated for 1 h at
37uC in PBS with 3% bovine serum albumin (BSA) and 0.2%
Triton X100. The primary antibody for Egr1 (C19, Santa Cruz)
was diluted 1/2000 in PBS with 1% BSA and 0.2% Triton X100
and incubated for 16 h at 4uC. After 3 rinses in PBS, coverslips
were incubated with anti-rabbit antibody coupled to cyanine-3
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at 37uC. After 3 washes, coverslips were mounted in medium
containing 4969-diamidino-2-phenylindole (DAPI) (Vector Labo-
ratories) and neurons examined by epifluorescence microscopy.
For each condition, about 1,400 neurons were counted on 3
coverslips independently by two experimenters (SC and LD).
For microtubule-associated protein 2 (MAP2) and Tau labelling,
neurons were fixed as above, rinsed in PBS, and saturated for 1 h
at 37uC with PBS containing 10% fetal calf serum (FCS) and
0.05% Tween 20. The primary monoclonal antibody for MAP2
(1/500, Chemicon International) and polyclonal affinity purified
anti-Tau (1/2000, AbCam) were diluted in saturation buffer and
Figure 1. Changes in cell adhesion and in neuronal morphology induced by sAPPa, sAPPb and sAPP-Fc added to neurons after 1
DIV. (A) 5DIV neurons were immunostained for MAP2 (green) and Tau (red). Representative confocal merged images show that the longest neurite is
stained for Tau, an axonal marker, in control (Ctrl) neurons or after addition of sAPP-Fc to 1DIV neurons. Scale Bar: 10 mm. (B) Adhesion is significantly
reduced after sAPPa or sAPPb (50 to 150 nM). sAPPa and sAPPb were added to primary neurons after 1DIV and adhesion assays were performed
24 hours later. (50 nM: control (Ctrl) vs sAPPa:p ,0.001, control vs sAPPb:p ,0.04; 100 nM: control vs sAPPa:p ,0.0001, control vs sAPPb:p ,0.0005;
150 nM: control vs sAPPa:p ,0.003, control vs sAPP-Fc: p,0.005, control vs sAPPb:p ,0.01). (C–E) Morphometric analysis 96 hours after the addition
of sAPPs (50 to 150 nM) to 1DIV primary neurons. (C) At 50 and 100 nM sAPPa and sAPPb induce a significant decrease of primary dendrite length
while at 150 nM, the decrease in primary dendrite length is still significant for sAPPb only (50 nM: control (Ctrl) vs sAPPa:p ,0.0001, control vs sAPPb:
p,0.0001; 100 nM: control vs sAPPa:p ,0.0001, control vs sAPPb:p ,0.0001; 150nM: control vs sAPPa: NS, control vs sAPP-Fc: NS, sAPPa vs sAPP-Fc:
NS, control vs sAPPb:p ,0.0001). (D) At 150 nM sAPPa, sAPP-Fc and sAPPb induce an increase of axon elongation (150 nM: control (Ctrl) vs sAPPa:
p,0.005; control vs sAPP-Fc: p,0.002; control vs sAPPb:p ,0.003; sAPPa vs sAPPb: NS; sAPPa vs sAPP-Fc: NS; sAPPb vs sAPP-Fc: NS). At 100 nM
sAPPa was already significant (100 nM: control vs sAPPa:p ,0.034). (E) shows a significant decrease of the number of primary dendrites for sAPPa,
sAPP-Fc and sAPPb at 150 nM and starting at 100 nM for sAPPa (100 nM: control (Ctrl) vs sAPPa:p ,0.035; 150 nM: control vs sAPPa:p ,0.0001,
control vs sAPP-Fc: p,0.0001; control vs sAPPb:p ,0.0001). The data presented are the mean of 3 independent experiments. Statistical analysis was
done with ANOVA and Scheffe’s post-hoc test.
doi:10.1371/journal.pone.0016301.g001
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with anti-mouse antibody conjugated to Alexa-488 (1/200,
Jackson ImmunoResearch) and cyanine-3 anti-rabbit antibody
(1/500, Jackson ImmunoResearch) for 1 h at 37uC. After washes
in PBS, coverslips were mounted in a medium containing DAPI
and neurons examined by confocal laser scanning microscopy.
Real time PCR for quantification of mRNA levels
Neurons after 1DIV were incubated or not for 1 h with 5 mM
of ERK1,2 inhibitor (UO126, Sigma) then for 50 min with
sAPPs. The medium was removed, the cells were washed once in
PBS and then collected by scraping. Total RNA was extracted
u s i n gt h eR N e a s ym i n ik i ta n dt r e a t e dw i t hD N a s e I( Q i a g e n ) .
cDNAs were obtained from total RNA samples using a High
Capacity cDNA Reverse Transcription kit (Applied Biosystems).
Briefly, 20 ml of reaction mixture containing 100 ng of total
RNA, 1X reverse transcription buffer, 1 mM of each dNTP, 1X
reverse transcription random primer and 50U of MultiScribe
reverse transcriptase were incubated at 25uC for 10 min followed
by incubation at 37uC for 2 h. The reaction was stopped by
heating at 85uC for 5 sec. Real time PCR was performed using
an Abi Prism 7000 (Applied Biosystems) and the Absolute SYBR
Green ROX Mix (ThermoScientific). 25 ng of cDNAs were
mixed with 0.07 mM of each primer, 1X SYBR Green Mix and
PCR-grade water to a final volume of 25 ml. The cycling
conditions for all primers (Egr1 forward: 59-GGGGAGCC-
GAGCGAACAAC-39,E g r 1r e v e r s e :5 9-TGATGGGAGG-
CAACCGAGTC-39, b actin forward: 59-CCCCAACTTGA-
TGTATGAAG-39 and b actin reverse: 59-GCACTTTTA-
TTGGTCTCAAG-39)w e r e5 0 uCf o r2 m i n ,t h e n9 5 uCf o r
15 min followed by 40 cycles consisting of two steps, 15 sec at
95uCa n d1m i na t6 0 uC. The PCR program was completed by a
melting temperature analysis consisting of 15 sec at 95uC, 20 sec
at 60uC and then steps through which temperature ranged from
60 to 95uC. Amplification plots were produced to calculate the
t h r e s h o l dc y c l e( C t )a n ds t a n d a r dc u r v e so fC tv e r s u sl o gc D N A
dilution were generated for both target and reference genes.
Since all reactions were done in triplicate, the average Ct was
used. Relative quantification was calculated using the 2
-DDCt
method. Relative expressions of the genes were assessed in the
sAPPs (sAPP-Fc, sAPPa and sAPPb)a n dU O 1 2 6t r e a t e dn e u r o n s
compared to the corresponding untreated cells.
Egr1 mutant mice
Embryos E16 from Egr1 heterozygous pregnant mice (C57Bl/
6J background) were genotyped using the tail of each embryo as
described [21]. Briefly, a mixture of three oligonucleotides was
used for PCR amplification: a common 59-primer mapping in the
Egr1 coding sequence (59-GAGTGTGCCCTCAGTAGCTT-39)
and two different 39-primers, mapping in the Egr1 coding
sequence (59-GGTGCTCATAGGGTTGTTCGCT-39) and in
the lacZ-coding sequence (59-AACGACTGTCCTGGCCG-
TAACC-39), respectively. PCR amplification was performed with
Taq polymerase (ABGene) under the conditions recommended by
the supplier and involved 30 cycles consisting of 1 min at 92uC,
2 min at 60uC, and 2 min at 72uC.
At the same time, the cortex of each embryo was dissected,
dissociated and distributed individually for primary neuronal
cultures in plastic wells of 16.2 mm diameter at a density 15610
3
neurons/well. Then sAPPs were added the next day and 4DIV
later, the cells were fixed, stained for b tubulin and morphometric
analyses were performed.
Results
sAPPa and sAPPb induce a decrease of cell adhesion and
an increase of the axon length in vitro independently of
the post-translational modifications
We previously produced a recombinant protein of human
sAPPa 695 fused to the Fc domain of human immunoglobulin in
the conditioned medium of transfected Cos-7 cells [5]. This
recombinant protein bears all the post-translational modifications
observed in eukaryotic cells. Here, we generated two other
recombinant proteins for sAPPa and sAPPb produced in bacteria.
The recombinant proteins (50 to 150 nM final concentrations)
were added to cultures of embryonic primary cortical neurons
after 1 day in vitro (DIV) and 96 hours later, the cells were fixed
and stained for b tubulin for morphometric analysis. Using double
staining for MAP2 and Tau, we verified that in 5DIV neurons the
longest neurite was the axon in control neurons as well as in
neurons after addition of any of the 3 recombinant proteins to
1DIV (Fig. 1A).
Since substrate adhesion influences the development of axon
and dendrites in vitro, we first analyzed the effect of sAPPa and
sAPPb on the adhesion to 1DIV primary neurons [19,20,22].
Figure 2. Changes in neuronal morphology after 150 nM sAPP-Fc added to 5DIV neurons. Morphometric analysis 96 hours after the
addition of 150 nM sAPP-Fc to 5DIV neurons shows that: (A) sAPP-Fc induces a significant decrease of primary dendrite number (control (Ctrl) vs
sAPP-Fc: p,0.0276). (B) sAPP-Fc does not modify primary dendrite length (control vs sAPP-Fc: NS). (C) sAPP-Fc induces an increase of axon
elongation (control vs sAPP-Fc: p,0.0297). The data in A-C are the mean of 3 independent experiments. Statistical analysis was done with ANOVA
and Scheffe’s post-hoc test.
doi:10.1371/journal.pone.0016301.g002
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24 hours after the addition of sAPPa and sAPPb and this decrease
was similar for final concentrations of 50 nM to 150 nM (Table S1
and Fig. 1B). Morphometric analysis 96 hours after addition of
sAPPa and sAPPb to 1DIV neurons showed a significant decrease
of primary dendrite length at concentrations of 50 to 100 nM for
sAPPa and to 150 nM for sAPPb (Table S1 and Fig. 1C). At
150 nM sAPPa and sAPPb showed a similar and significant
increase of axon outgrowth (Table S1 and Fig. 1D). This increase
was also significant at 100 nM for sAPPa (Table S1 and Fig. 1D).
The increase of axon outgrowth induced by sAPPa and sAPPb
was associated with a significant decrease of the number of
primary dendrites (Table S1 and Fig. 1E). Similar changes in cell
adhesion and morphology were observed with sAPP-Fc suggesting
that post-translational modifications are not required for the effects
on neurite outgrowth induced by sAPPa (Table S1 and Fig. 1B–E).
When 150 nM sAPP-Fc was added to cultures already 5DIV when
the differentiation is complete and then examined 96 hours later,
we observed similar morphological changes in the number of
primary dendrites, primary dendrite length and axonal elongation
that we observed when the protein was added to 1DIV neurons
(Table S1 and Fig. 2). Furthermore, the increase in axonal
outgrowth after the addition of sAPP-Fc to 5DIV neurons reached
the same length (Mean 6S.E.M.: Ctrl: 102.8611.5 mm; sAPP-Fc:
132.6610.2 mm) as that when the protein was added to 1DIV
neurons (Ctrl: 9066.8 mm; sAPP-Fc: 12769.2 mm), which ap-
pears to be the maximum axonal length response to this amount of
sAPP-Fc.
Egr1 is induced by sAPPs
We have recently shown that MAPK/ERK is activated early by
sAPPa in differentiating neurons [17]. Here, we tested whether
UO126, a specific inhibitor of ERK, abolished the sAPPs-induced
increase in axonal elongation (Table S1 and Fig. 3). The genes
downstream of ERK that act directly on neurite outgrowth have
not been determined. Egr1 is one possible candidate, since in
PC12 cells NGF induces Egr1 downstream of ERK and EGR1 is
required in the differentiation of neuroblastoma cells [23,24]. We
used real time PCR to examine Egr1 transcript levels at short
times after the addition of sAPPs and observed a maximum
response at 50 min. We observed a similar significant increase of
Egr1 transcript with the 3 recombinant proteins (Fig. 4A). This
action on Egr1 was abolished when UO126 was added 1 hour
before sAPPs, suggesting that Egr1 acts downstream of MAPK
(Fig. 4A). We confirmed this at the protein level using an antibody
specific for Egr1. We detected a significant increase in the number
of intensively EGR1 labeled neurons 2 hours after the addition of
sAPPs. This increase was blocked by the addition of UO126
1 hour before sAPPs (Fig. 4B–C).
Egr1 induced by sAPPs is directly involved in the axon
outgrowth in response to sAPPs
To examine whether Egr1 was involved in sAPPs-induced axon
outgrowth, we used embryonic primary neurons from Egr1
mutant mice. In each litter we genotyped each embryo and plated
neurons from wild type, heterozygous and homozygous animals
separately for 1DIV before adding sAPPs. 96 hours later the cells
were fixed and morphological analyses performed. We observed a
significant increase in axon length after the addition of sAPP-Fc
and sAPPb to cultures of neurons from wild type and heterozygous
embryos but no increase in cultures of neurons from homozygous
mutant animals (Table S2 and Fig. 5). Interestingly, sAPPb
induced a significant decrease of dendrite length in primary
neurons from all genotypes suggesting that the effects on dendrite
reduction and axon outgrowth may be regulated by different
pathways. 150 nM sAPP-Fc had no effect on dendrite length
regardless of the genotype and this is similar to what we observed
in primary neurons from wild type mice with another genetic
background (Fig. 1, Fig. 5). These data suggest that Egr1 is directly
required in the sAPPs-induced axon outgrowth and not in dendrite
outgrowth responses.
Discussion
sAPPb and sAPPa induce similar morphological changes
in primary neurons
sAPPb induces an increase in axon outgrowth that is similar to
that caused by sAPPa. This effect on axon outgrowth is
independent of post-translational modifications on the proteins.
Figure 3. UO126 inhibits changes in neuronal morphology
after 150 nM sAPP-Fc added to 1DIV neurons. UO126 was added
to neurons after 1DIV 1 hour before the addition of 150 nM sAPP-Fc.
Morphometric analysis was performed 48 hours later. (A) UO126 does
not induce any change in primary dendrite length by itself nor in
combination with sAPP-Fc (control (Ctrl) vs sAPP-Fc: NS; control vs
UO126: NS; control vs UO126+ sAPP-Fc: NS). (B) UO126 1 hour before
the addition of sAPP-Fc significantly reduces the growth of axons
induced by sAPP-Fc (control vs sAPP-Fc: p,0.0001; control vs UO126:
NS; control vs UO126+ sAPP-Fc: NS). The data presented in A and B are
the mean of 3 independent experiments. Statistical analysis was done
with ANOVA and Scheffe’s post-hoc test.
doi:10.1371/journal.pone.0016301.g003
sAPPb and a Induce Axon Length via Egr1
PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e16301sAPPb and a Induce Axon Length via Egr1
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elongation was already present at a lower concentration,
suggesting that the 16 amino-acids lacking in the C-terminal part
of sAPPb bears some information for accelerating the axonal
outgrowth.
The increase in axonal outgrowth induced by sAPPa and
sAPPb is likely linked to the decrease in cell adhesion. A
relationship between axonal outgrowth and decreased adhesion
has previously been described and has been attributed to changes
in the cytoskeleton [19,20,22]. Large amounts of fasciculated
microtubules in the axon may increase axon cytoplasmic viscosity
and require less adhesion to the substrate. Conversely, dendrite
elongation is related to a strong cellular adhesion and to low
viscosity [19,20,22]. In our studies the decrease in adhesion is the
first event after addition of sAPPs and is observed 24 hours later
and at all concentrations of 50 to 150 nM. Then, the decrease in
dendrite outgrowth occurs 72 hours later, starting at concentra-
tions of 50 nM, suggesting that the decrease in cell adhesion either
stops or prevents the growth of dendrites, as has been observed by
others using heparan sulfate on primary neurons [19,20,22]. The
decrease in adhesion leads to the simultaneous elongation of the
axon and retraction of some primary dendrites starting at 100 nM
for sAPPa and 150 nM for sAPPb. Retraction of primary
dendrites may be necessary for axonal outgrowth in that the
soma will have a lower adhesion and this will allow the axon to
grow. Although the decrease in cell adhesion and in dendrite
outgrowth were equivalent at 50 and 100 nM, a higher
concentration of sAPPa was necessary for increasing axonal
Figure 5. The primary cortical neurons from E16 homozygous knock out embryos for Egr1 do not respond to sAPPs. 150 nM sAPP-Fc
or sAPPb were added on 1DIV primary neurons from Egr1 wild type (WT), heterozygous (HT) and homozygous (KO) embryos. Morphometric analysis
was performed 96 hours later. Upper row: A significant increase of axonal outgrowth is observed with sAPP-Fc and sAPPb for neurons from WT and
HT embryos but not from KO neurons (WT: control (Ctrl) vs sAPP-Fc: p,0.0001, control vs sAPPb:p ,0.0001; HT: control vs sAPP-Fc: p,0.001, control
vs sAPPb:p ,0.0001; KO: control vs sAPP-Fc: NS, control vs sAPPb: NS). Lower row: Primary dendrite length is significantly decreased for sAPPb in the
3 genotypes (WT: control vs sAPP-Fc: NS, control vs sAPPb:p ,0.0001; HT: control vs APP-Fc: NS, control vs sAPPb:p ,0.0001; KO: control vs APP-Fc:
NS, control vs sAPPb:p ,0.0001). The data presented are the mean of 3 independent experiments. Statistical analysis was done with ANOVA and
Scheffe’s post-hoc test.
doi:10.1371/journal.pone.0016301.g005
Figure 4. sAPPa, sAPPb and sAPP-Fc induce Egr1 expression. (A) Real time PCR for each recombinant protein added to 1DIV neurons for 50
minutes shows a 2-fold increased expression of Egr1 compared to controls (Ctrl). The addition of UO126 1 hour before the addition of sAPPs
significantly decreases Egr1 expression (sAPP-Fc/control after UO126 vs sAPP-Fc/control: p,0.0001; sAPPa/control after UO126 vs sAPPa/control:
p,0.0001; sAPPb/control after UO126 vs sAPPb/control: p,0.0015). (B) Egr1 immunofluorescence 2 hours after the addition of sAPPs. The nuclear
labelling by DAPI is presented and the merged images show an increase of Egr1 protein in the nucleus after sAPPs. Scale Bar: 10 mm. (C)
Quantification of the % of nuclear Egr1 positive neurons 2 hours after addition of sAPPs only and after addition of UO126 1 hour before sAPPs
(control (Ctrl) vs sAPP-Fc: p,0.0001; control vs sAPPa:p ,0.0001; control vs sAPPb:p ,0.0001, control vs UO126: NS; sAPP-Fc vs UO126+ sAPP-Fc:
p,0.0001; control vs UO126+ sAPPa:p ,0.0001; control vs UO126+ sAPPb:p ,0.0001). For each condition, about 1,400 neurons were counted on 3
coverslips. The data presented in A and C are the mean of 3 independent experiments. Statistical analysis was done with ANOVA and Scheffe’s post-
hoc test.
doi:10.1371/journal.pone.0016301.g004
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for promoting axon outgrowth. At 150 nM, the highest concen-
tration used, some dendrite outgrowth occurs with both sAPPa
and sAPP-Fc as if the decrease in dendrite outgrowth observed at a
lower concentration was lost. The increase of dendrite outgrowth
after 150 nM sAPPa and sAPP-Fc indicates that the maximal
axonal outgrowth is reached and that dendrite outgrowth can
occur. Here, we cannot exclude that the same can be observed for
sAPPb at a higher concentration. Interestingly, this increase of
dendrite outgrowth at 150 nM reflects what occurs during brain
embryogenesis where the neurons generated in the germinal zone
migrate to their normal position extending their axons and
elaborating their dendritic tree once the axon terminals have
reached their target [22].
Two domains in sAPPa one located between residues 319–335
and the other between residues 96–110 have been shown to
convey neurotrophic effects [13,14]. The latter is a heparin
binding domain that interacts with HSPGs [14]. The effects of
sAPPa and sAPPb on axonal outgrowth that we observe here are
associated with a decrease in cell adhesion that is similar to what
has been described for heparan sulfate on primary neurons
[19,20]. Indeed, previous reports have shown that heparan sulfate
added to neurons in vitro after plating induce a specific increase of
axonal outgrowth associated to a decrease of cell adhesion and a
clear absence of dendrites, while dermatan sulfate increases the
cell adhesion and stimulates mostly dendrite outgrowth [20].
When full length APP is bound to the substratum, HSPGs appear
to be necessary to stimulate neurite outgrowth and the physiologi-
cal responses observed varies with HSPG type [25–27]. Although
we observed that sAPPs can interact with some HSPGs in the
conditioned medium of 1DIV primary neurons (not shown), we do
not yet know if this interaction accounts for the effects of sAPPs that
we report here.
The 16 amino acids lacking in the sequence of sAPPb have been
shown to be a heparin binding domain as well [13]. This domain
appears not to be necessary for increasing axon outgrowth, but it is
required for neuroprotection and LTP [13,7]. The addition of
sAPPs was performed to 1DIV neurons, a time where the
differentiation machinery starts, and to 5DIV when the neurons
are already differentiated. In that case, the addition of 150 nM
sAPP-Fc induces an increase of axonal outgrowth that reaches the
same length as that after addition to 1DIV, and which appears to
be the maximum axonal growth response. The action of sAPP-Fc
on neurons after 5DIV suggests that in cases of neurite retraction
in vivo following insults to neurons, the sAPPs might be
therapeutically useful for recovery of synaptic connections. Indeed,
sAPPa is able to protect against ischemic brain injury [28]. The
mechanisms of sAPPa action including a putative receptor are not
known. sAPPa interacts with the cell surface of 3 different cell lines
[29] and we previously observed such binding with neuroblasts
derived from the subventricular zone and grown as neurospheres
in which sAPPa stimulates proliferation [5]. In primary neurons
we observed sAPP-Fc binding at the cell surface (not shown) but
we have yet to identify molecular partners for this binding. We
recently reported that the N-methyl-D-aspartic acid receptor is
required for the sAPPa induced neurite outgrowth from neural
stem cell-derived neurons [17]. sAPPa can compete with APP at
the cell surface for integrin b1 interaction resulting in an increase
in neurite outgrowth via integrin signaling [30]. Whether this is
also the case for sAPPb has not yet been determined. Since the
increase in axon elongation is first observed at 100 nM for sAPPa,
it is possible that the 16 amino acids lacking in the sAPPb play a
role in this physiological effect and/or be responsible for a
conformational change reducing the effects of the two upstream
domains (319–335 and 96–110 amino-acids) to a putative
membrane receptor for this physiological response.
These data and the recent report showing that b-amyloid
monomers are neuroprotective suggest that cleavage by b secretase
is not deleterious per se [31]. It does not preclude that sAPPb can
act in a death signal when a partner like DR6 is highly expressed
[12].
Egr1 is a key step in the sAPPs-induced axonal
elongation
We previously showed that MAPK/ERK is activated early in
sAPPa induced neurite outgrowth [17]. Egr1 activation has
already been shown to be downstream of ERK1/2. In PC12 cells,
NGF stimulates ERK inducing Egr1 expression [23,24]. In this
case, Egr1 mediates the induction of p35 activating Cdk5, which is
necessary for neurite-like outgrowth. Here we observed an
increase in Egr1 transcript 50 min after addition of the
recombinant sAPPa, sAPPb or sAPP-Fc. The contribution of
Egr1 is downstream of MAPK/ERK pathway since it is inhibited
by UO126. The MAPK/ERK pathway is not involved in changes
in primary dendrites since we observed no effects on control or on
sAPP-Fc-treated neurons in the presence of UO126. When sAPPs
were added to primary neurons from embryonic mice homozy-
gous for Egr1, an increase in axon outgrowth was not observed as
in neurons from embryonic wild type mice from the same litter,
while the effects on dendrite outgrowth were observed with all
genotypes. These data suggest that Egr1 signaling occurs at the
beginning of axon elongation induced by sAPPs and not through
an effect on dendrite outgrowth. We did not observe any
significant morphological differences in the responses of embry-
onic neurons from wild type and heterozygous mutant mice,
suggesting that one functional allele of Egr1 is sufficient to
promote axonal elongation induced by sAPPs. The fact that
neurons from mice homozygous for Egr1 are unable to respond to
sAPPs with an increase in axon outgrowth suggests that Egr1 is a
key component in the signaling pathway and that this step is not
compensated by other genes. Interestingly, a previous report that
used the same mutant mice showed a deficit in late LTP and long-
term memory and established that Egr1 is required for these
functions [32]. Indeed, sAPPa has been shown to increase LTP
and spatial memory [7]. It is interesting to speculate about
whether the expression of Egr1 that is necessary for LTP is
dependent of sAPPa. If this is the case, it will be important to
understand why sAPPb stimulates axon elongation through Egr1
while it does not act in LTP [7]. Whether Egr1 is also a key step in
the neuroprotective or neuroproliferation functions of sAPPa
remains to be determined.
Supporting Information
Table S1 Presentations of parameters investigated in
Figures 1, 2, and 3. In Figure 1, sAPPs was added to 1DIV
neurons at concentrations of 50 to 150 nM; cell adhesion and
morphometric analysis was performed 24 hours and 96 hours
later, respectively. In Figure 2, sAPP-Fc at 150 nM was added to
5DIV neurons and morphometric analysis was performed 96
hours later. In figure 3, UO126 was added 1 hour before sAPP-Fc
at 150 nM on neurons after 1DIV and morphometric analysis was
performed 48 hours later. The data are expressed as the Mean 6
S.E.M. The levels of significance are indicated by a star and
described in the corresponding legends of Figs. 1, 2, and 3. The
primary neurons were from mouse embryonic cortex of E16 Swiss
strain mice.
(DOC)
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Figure 5. In Figure 5, 150 nM sAPP-Fc or sAPPb were added to
1DIV embryonic cortical neurons from wild type (WT), heterozy-
gous (HT), homozygous (KO) neurons from Egr1 (C57Bl/6J
background) mutant mice. Morphometric analysis was performed
96hourslater.ThedataareexpressedasMean 6S.E.M.Thelevels
of significance are indicated by a star and detailed in the legend of
Fig. 5.
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